Skip to main content
Fig. 4 | Respiratory Research

Fig. 4

From: Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study

Fig. 4

The impact of types of preexisting interstitial lung disease on mortality in COVID-19 patients in the total period and each wave. Adjusted odds ratios and 95% confidence intervals were plotted. Multivariate logistic regression models adjusted for age, sex, wave, and comorbidities in the total period, and adjusted for age, sex, and comorbidities in each wave. Total period, January 01, 2020–August 31, 2021; wild-type-predominant wave, January 01, 2020–April 18, 2021; alpha-predominant wave, April 19, 2021–July 18, 2021; delta-predominant wave, July 19, 2021–August 31, 2021. CI, confidence interval; DM, dermatomyositis; ILD, interstitial lung disease; MPA, microscopic polyangiitis; OR, odds ratio; PM, polymyositis; RA, rheumatoid arthritis; SjS, Sjogren syndrome; SLE, systemic lupus erythematosus; SSc, systemic sclerosis

Back to article page